Lip SCC
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| T1 Squamous Cell Carcinomas of the Lip (NCT05610293) | Maastricht University Medical Center | 2021-04-01 |
| Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma (NCT03082534) | University of California, San Diego | 2017-03-28 |
Track Lip SCC automatically
Every clearance here is in the API, with alerts when new ones post.